NCT02582931View on ClinicalTrials.gov

MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 2, 2015

Primary Completion Date

May 14, 2018

Study Completion Date

December 13, 2018

Conditions
Cancer of OvaryCancer of the OvaryNeoplasms, OvarianOvarian CancerOvary CancerOvary Neoplasms
Interventions
DEVICE

MRI-guided SBRT

BEHAVIORAL

EORTC QLQ-C30 Questionnaire

30 questions with 28 questions having answers that range from 1 (not at all) to 4 (very much) and the other 2 questions have answers that range from 1 (very poor) to 7 (excellent)

BEHAVIORAL

EORTC QLQ-OV28 Questionnaire

28 questions having answers that range from 1 (not at all) to 4 (very much)

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT02582931 - MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer | Biotech Hunter | Biotech Hunter